Staff editor

MaaT Pharma set to showcase groundbreaking preclinical results in cancer immunotherapy

Preclinical findings will be presented at the American Association for Cancer Research (AACR) Annual Meeting in Chicago.

Inner Brightness’s Akkermansia muciniphila: a breakthrough in the gut health market

This pioneering three-in-one formula uniquely combines pasteurized Akkermansia muciniphila AKK PROBIO, DigeSEB® broad-spectrum digestive enzymes, and B-Complex vitamins.

Decoding host-microbiome interactions: Kanvas Biosciences’ AI-powered spatial biology platform

Matthew Cheng, CEO of Kanvas Biosciences, introduces the company’s cutting-edge spatial biology platform, developed to provide deeper insights into host-microbiome interactions.

Gut bacteria improve autism-like behaviors in mice

Treatment with the probiotic Lactobacillus murinus improved social behavior and partially restored gut and brain function.

InnoGI Technologies: advancing gut microbiome research with mucus-enhanced models

Maitrayee Chatterjee, Ph.D., Project Manager and Senior Scientist at InnoGI Technologies, discusses their innovative and non-invasive platform to mimic both the upper and lower gastrointestinal tract, offering precise and standardized…

Lallemand Health Solutions launches Cerenity, a clinically studied probiotic formula to support healthy aging

Cerenity™ improves mobility, strength, and muscle function in older adults by modulating the gut-muscle axis.

NIST redefines gut microbiome research with breakthrough reference material

The Human Gut Microbiome Reference Material (RM) promises to standardize and enhance research efforts in a field poised to transform healthcare.

MaaT013 cleared for pediatric trials: EMA approval marks key milestone for microbiome therapy in aGvHD

MaaT013, a Microbiome Ecosystem Therapy™ (MET), is designed to restore the gut microbiome in pediatric patients aged 6 to 18 years with steroid-resistant aGvHD.

Skin microbiome

The skin is not merely a protective barrier; it is a complex, dynamic ecosystem populated by billions of microorganisms that play essential roles in maintaining skin health.

Resetting the immune system: HMOs as a promising treatment for Gut-Brain Axis disorders

Emil Chuang, Chief Medical Officer at Intrinsic Medicine, explores the growing understanding of gut-brain axis disorders and the potential of Human Milk Oligosaccharides (HMOs) in their treatment. 

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top